Biotech Capital Cycle — AI-Bio Platforms & Lab-Tools/CRO Picks-and-Shovels (IPO-Window Levered)

perspective

Biotech Capital Cycle — AI-Bio Platforms & Lab-Tools/CRO Picks-and-Shovels (IPO-Window Levered)

active thesis

status monitoring priority medium thesis tickers 8 scan-mentioned tickers 141 events 30 latest

The AI-drug-discovery / lab-automation / life-science-tools / CRO complex all sells to biotech, so it lives and dies on the biotech funding cycle. Coming off a multi-year funding winter (IPOs frozen, VC dry, trial demand + instrument capex cut) that de-rated the group together; bull thesis is the IPO window reopening this year = funding returns = beaten-down, operating-leverage-heavy group re-rates. Same liquidity-returns driver as the AI mega-IPO supercycle parent frame (cross-link spacex-ipo-liquidity-event, OPPOSITE sign: SpaceX drains liquidity June 12, a healthy biotech issuance regime returns it). STRUCTURAL FACT: best assets are private/locked (Lila/Flagship, Isomorphic INSIDE GOOGL, Xaira, Insitro, Hamilton, Opentrons all private; Boehringer family-owned) — so the public expression is thin and tilted to the shovels, not the AI. LOAD-BEARING FINDING (2026-06-04 tape): the rotation is ALREADY underway and BIFURCATED — mid-cap tools+CROs running hot (RSI 70-82: BRKR/TXG/TWST/ICLR/FTRE/A near 52wk highs), while the LAGGARDS are the mega-cap anchors the user knows/owns (TMO -6% 3m, DHR -9%, MTD -8%, MEDP -2%) plus un-re-rated AI-bio platforms (RXRX/TEM/DNA, -47 to -49% off…

Watch for: ESCALATION (→ high): a hot biotech IPO prices well + XBI breaks its downtrend + CRO book-to-bill (IQV/MEDP/ICLR/CRL next prints) turns up — funding cycle confirmed turning; rotate into the LAGGARD expressions before they catch up. RATIFICATION GATE: rotation is real once TMO/DHR/MEDP put in positive 3m + RSI > 60 TOGETHER (mega-cap money joining the mid-cap front-run, vs current fast-money front-run). DE-ESCALATION (→ monitoring/low): IPO window stays shut / fresh biotech funding scare → CROs+tools roll back over (mid-cap melt-up was a head-fake). L1 INVALIDATION: AI-bio platforms (RXRX/TEM/DNA) failing to show commercial ROI kills the platform leg regardless of the cycle. Catalyst-verify BR...

cycle3d agoas of
paradigm track record untested — no scored verdicts · low confidence · n=0 cycle

The thesis basket — the 8 tickers this perspective actually tracks. Everything else it has touched is folded below.

TMO $585.51 +10.0% 30d in trend DHR $202.63 -0.6% 30d coming into play IQV $241.24 +17.0% 30d in trend MEDP $597.12 +11.0% 30d in trend RGEN $169.04 +14.8% 30d in trend TWST $124.41 +32.6% 30d in trend SDGR $17.40 +13.6% 30d coming into play ABCL $11.20 +73.1% 30d in trend
Seen alongside in scans (40 shown of 133) — symbols that appear with this perspective, not the thesis basket
AAL $14.43 -3.7% 30d coming into play AAPL $305.59 -8.4% 30d coming into play ABSI $9.24 +11.3% 30d coming into play ABVX $120.73 -11.7% 30d coming into play ACHC $30.00 -13.0% 30d coming into play AGIO $33.63 -15.1% 30d coming into play ALAB $320.17 +5.5% 30d coming into play ALMR $32.13 +23.8% 30d too-young AMAT $535.31 +1.1% 30d coming into play AMD $506.00 +2.1% 30d coming into play AMKR $61.30 -2.6% 30d coming into play AMZN $261.31 +5.7% 30d in trend ARKG $44.04 +10.5% 30d in trend ARQQ $24.35 +39.8% 30d coming into play ASHR $35.20 +4.7% 30d coming into play ASML $1,883.12 +7.9% 30d in trend ASX $39.91 +3.9% 30d coming into play ATAI $7.24 +0.3% 30d in trend ATKR $93.71 +27.6% 30d in trend AVGO $392.43 +5.8% 30d coming into play AVTR $13.50 +21.9% 30d coming into play BABA $124.71 +8.5% 30d retreating BE $232.16 +8.0% 30d coming into play BEAM $27.10 -1.6% 30d coming into play BRBR $10.18 -16.0% 30d retreating BRUN $22.63 -7.3% 30d coming into play BUG $41.89 +2.5% 30d in trend CDNA $46.38 +16.7% 30d in trend CEG $278.20 +10.2% 30d retreating CERT $8.00 +15.4% 30d coming into play CLSK $12.41 -4.8% 30d retreating COP $127.56 +11.2% 30d coming into play CRDO $282.82 +39.5% 30d coming into play CRL $286.64 +27.8% 30d in trend CRNX $84.75 +1.1% 30d in trend CROX $129.97 -5.2% 30d in trend CRWD $213.90 +5.3% 30d in trend CVX $202.70 +8.2% 30d coming into play DAL $87.59 +4.1% 30d in trend DD $143.07 +5.8% 30d coming into play
Show all 133 ticker links
$AAL$AAPL$ABSI$ABVX$ACHC$AGIO$ALAB$ALMR$AMAT$AMD$AMKR$AMZN$ARKG$ARQQ$ASHR$ASML$ASX$ATAI$ATKR$AVGO$AVTR$BABA$BE$BEAM$BRBR$BRUN$BUG$CDNA$CEG$CERT$CLSK$COP$CRDO$CRL$CRNX$CROX$CRWD$CVX$DAL$DD$DELL$DIA$DK$DPZ$DRAM$DUK$ENTG$EQNR$ERO$FORM$FTNT$FTRE$FXI$GE$GENB$GLD$GLW$GOOGL$HACK$HAL$HIMS$HQ$IBB$ICHR$IONQ$IOVA$IWM$JETS$JNJ$KLAC$KLIC$KWEB$KYMR$LABU$LAD$LEU$LLY$LRCX$LULU$MAN$MARA$MKSI$MRNA$MRVL$MSFT$MSTR$MTUM$MU$NKE$NVDA$OIH$OKTA$OSCR$PANW$PLTR$PYPL$QQQ$RARE$RIOT$RSP$SBUX$SLB$SLV$SNDK$SOXS$SPCQ$SPY$SSPC$STX$TER$TLT$TSLA$TXG$UNH$USO$UUP$VG$VIXY$VKTX$VPG$VRTX$VST$VTI$VTV$WDC$XBI$XE$XLC$XLE$XLI$XLK$XOM$ZS

Desk commentary

Authored analysis and challenge notes tied to Biotech Capital Cycle — AI-Bio Platforms & Lab-Tools/CRO Picks-and-Shovels (IPO-Window Levered).

2

The Thread

The thesis as it unfolds — by source type (the symbol grid above is the current state).

Recent Shifts

11

Signals

2

Research

5

Captures

1

Calendar & Lifecycle

9